The 5-alpha reductase deficiency market is expected to grow to $1.73 billion in 2027 at a CAGR of 7.7%.

Newark, New Castle, USA, May 31, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global 5-alpha-reductase inhibitors (5-ARIs) market was conducted by Growth Plus Reports in 2022. The market is ...

This works studied the effect of purple corn extract (PCE) on improving BPH symptoms using a testosterone propionate (TP)-induced rat model. PCE reduced the enlargement and weight of the prostate ...

Trials on 5-alpha reductase inhibitors in prostate cancer prevention showed that they could significantly decrease the incidence of prostate cancer, but meanwhile increase high-grade cases as well.

Compared to placebo treatment, taking 5-alpha-reductase inhibitors (5-ARIs) can reduce a man's risk of being diagnosed with prostate cancer from around 5--9 percent to around 4-6 percent during up ...

This article is cited by 114 publications. Massimiliano Cuccioloni, Laura Bonfili, Valentina Cecarini, Massimo Nabissi, Riccardo Pettinari, Fabio Marchetti, Riccardo Petrelli, Loredana Cappellacci, ...

North America was the largest region in the 5-alpha reductase deficiency market in 2022. The regions covered in the 5-alpha reductase deficiency market report are Asia-Pacific, Western Europe, Eastern ...